drugset / Trial / NCT03747679

Palatability (Taste) of Oral Formulations of Bosutinib

NCT03747679

Phase 1 Completed 8 enrolled Pfizer
RandomizedSingle-groupSingle-blindOther

Summary

Healthy Adult Volunteer Taste Study of Oral Formulations of Bosutinib for Pediatric Use. This will be a single-blind, randomized, multiple-period (dosing over 4 days) study in healthy male and/or female participants. Approximately 8 participants will assess the sensory attributes of different powder for oral suspension (POS) formulations.

Timeline

Start
2018-11-22
Primary completion
2019-01-14
Completion
2019-01-14

Drugs

EvaluationDrugModalityDoseRoute
Background Bosutinib Small molecule 200 mg Oral